Close Menu

VANCOUVER, British Columbia (GenomeWeb) – At the American Society of Human Genetics annual meeting here yesterday, the BC Cancer Agency's Marco Marra shared his team's experiences with the first few hundred adult and pediatric cancer cases assessed through the ongoing Personalized Oncogenomics (POG) clinical trial.

Speaking as part of an Illumina-sponsored workshop at the conference, Marra noted that roughly 700 individuals have been enrolled in POG since the main project began in 2015, with more than 400 adult cases and nearly three-dozen pediatric cases sequenced so far.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Sponsored by
Beckman Coulter

This webinar will discuss a streamlined library preparation method for next-generation sequencing (NGS) that improves quality control testing capability while reducing the total number of steps compared to conventional multiplexed library workflows.

Sponsored by

NTRK fusions are oncogenic drivers in a variety of tumors.

Sponsored by

This webinar, Part 3 of the “Advances in RNA-based Biomarker Development for Precision Oncology” webinar series sponsored by GeneCentric Therapeutics, will discuss novel and emerging applications of RNA-based genomic analysis in precision oncology, form characterizing the tumor microenvironment to informing the development of immuno-oncology treatments.

Sponsored by

Circulating tumor DNA (ctDNA) can allow clinicians and researchers to better understand which patients are at high risk of recurrence and should be offered intensified chemotherapy or selected for clinical trials.